Zoll Medical’s Zenix monitor/defibrillator is now authorised beneath the European Union’s Medical Machine Regulation 2017/745, generally known as EU MDR.
The Zenix monitor/defibrillator acquired premarket approval (PMA) from the US FDA in October 2025.
Constructed from years of suggestions from clients, Zenix combines design and performance to automate workflows for ease-of-use, in response to the corporate. The gadget options a big, sturdy touchscreen and its on-the-fly customization permits healthcare professionals to make real-time changes.
Geared up with Zoll’s Actual BVM Assist and unique Actual CPR Assist expertise, Zenix provides healthcare suppliers real-time medical suggestions to enhance air flow high quality and ship high-quality CPR.1
The superior expertise of Zenix empowers EMS groups and hospital clinicians to make knowledgeable, assured choices and guarantee they’re delivering distinctive affected person care, each time, in response to the corporate.
“Whether or not you’re a hospital clinician or an EMS skilled, the Zoll Zenix monitor/defibrillator is designed to work the way in which you’re employed,” mentioned Elijah White, President of Zoll Acute Care Expertise. “Zenix is our most superior monitor/defibrillator, and but it’s extremely straightforward to make use of—nearly all capabilities of the gadget are accessible with three screen-touches or much less. Together with the X Sequence, R Sequence and Zoll M2, Zenix extends Zoll’s management in skilled displays/defibrillators with distinctive options and intuitive design.”
